Spain· ES:81572

PALONOSETRON QILU 250 MICROGRAMOS SOLUCION INYECTABLE EFG

A palonosetron product containing palonosetrón, registered in Spain by Qilu Pharma Spain S.L.. The same ATC class is registered in 18 of our 19 countries.

ATC A04AA05

Checked against AEMPS CIMA (Spain) on August 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about palonosetrónAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Palonosetron is registered in 18 of 19 countries.

Countries holding a registration under ATC A04AA05 (palonosetron), each read from that country’s own register.

This record: Spain, from AEMPS CIMA (Spain)
10 of them publish a price we can compare per daily dose

Search palonosetron products by name

Palonosetron · ATC A04AA05

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of palonosetron costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Palonosetron · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$124.11

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AEMPS CIMA (Spain)

Active substance: palonosetrón
Manufacturer: Qilu Pharma Spain S.L.
Country: Spain (ES)
ATC code: A04AA05
ATC class: Palonosetron
Defined daily dose: 0.5 mg, O
Reimbursed: Not published by this register
Source register: AEMPS CIMA (Spain)
Last checked: August 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

490 interactions on record for palonosetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check palonosetron against other medicines How interaction checks work

Palonosetron · interactions on record

490 records

139 severe
195 moderate
3 minor
153 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
FenfluramineA08AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Palonosetron in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All palonosetron products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Palonosetron Kalceks
Belgium · Palonosetron Fresenius Kabi, Palonosetron Juta
Bulgaria · Ферант
Cyprus · Ferant, Injosetron
Czechia · Ferant, Palonosetron Fresenius Kabi
Germany · Palonosetron Beta, Palonosetron Fresenius Kabi
Denmark · Palonosetron Kalceks, Palonosetron Macure
Estonia · Ferant, Palonosetron Kalceks
Finland · Palonosetron Fresenius Kabi, Palonosetron Macure
France · Palonosetron Kalceks, Palonosetron Reig Jofre
United Kingdom (Northern Ireland) · Palonosetron Fresenius Kabi, Palonosetron Hydrochloride Qilu Pharma Spain
Greece · Ferant, Injosetron
Croatia · Ferant, Palonozetron Kalceks
Hungary · Palonosetron Kalceks, Palonosetron Onkogen
Ireland · Palonosetron
Iceland · Aloxi, Palonosetron Accord
Italy · Palonosetron Dr. Reddy’s, Palonosetron Fresenius Kabi
Liechtenstein · Aloxi, Palonosetron Accord
Lithuania · Ferant
Latvia · Ferant, Palonosetron Kalceks
Malta · Ferant, Palonosetron Anfarm
Netherlands · Palonosetron Fresenius Kabi
Norway · Aloxi, Palonosetron Accord
Portugal · Ferant, Palanossetrom Fresenius Kabi
Romania · Ferant, Palonosetron Dr. Reddy’s
Sweden · Ferant, Palonosetron Fresenius Kabi
Slovenia · Ferant, Palonosetron Fresenius Kabi
Slovakia · Ferant, Palonosetron Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dae6afdd-5330-44f0-9a57-4891b1af835c
GET /v1/drugs/dae6afdd-5330-44f0-9a57-4891b1af835c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":1482879600000}",
  "nregistro": "81572",
  "substance": "palonosetrón"
}

API reference MCP server Plans

See everything about palonosetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console